Free tool
FAERS Monitor: Linezolid In Sodium Chloride 0.9% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 206473 or its brand name (Linezolid In Sodium Chloride 0.9% In Plastic Container, Linezolid). Reports on generic versions are filed under their own applications.
Reports
23,980
Serious
22,401
93% of reports
Hospitalization
10,675
Death reported
4,476
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use2,355
- drug ineffective1,888
- thrombocytopenia1,797
- anaemia1,498
- drug interaction1,199
- nausea1,065
- lactic acidosis927
- vomiting893
- neuropathy peripheral892
- acute kidney injury891
- pyrexia834
- serotonin syndrome818
- diarrhoea774
- pancytopenia764
- drug resistance747
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 57 |
| 2005 | 77 |
| 2006 | 197 |
| 2007 | 178 |
| 2008 | 158 |
| 2009 | 189 |
| 2010 | 175 |
| 2011 | 245 |
| 2012 | 245 |
| 2013 | 255 |
| 2014 | 290 |
| 2015 | 330 |
| 2016 | 705 |
| 2017 | 1,000 |
| 2018 | 2,433 |
| 2019 | 2,016 |
| 2020 | 2,181 |
| 2021 | 1,830 |
| 2022 | 2,198 |
| 2023 | 2,231 |
| 2024 | 2,466 |
| 2025 | 2,434 |
| 2026 | 2,090 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| serotonin syndromeSignal | 818 | 39.0 | 36.4 | 28,964 |
| drug resistanceSignal | 747 | 26.2 | 24.4 | 17,606 |
| lactic acidosisSignal | 927 | 25.8 | 24.2 | 21,488 |
| thrombocytopeniaSignal | 1,797 | 14.3 | 13.7 | 21,991 |
| pancytopeniaSignal | 764 | 12.1 | 11.3 | 7,715 |
| neuropathy peripheralSignal | 892 | 8.3 | 7.8 | 5,686 |
| anaemiaSignal | 1,498 | 6.9 | 6.6 | 7,613 |
| drug interactionSignal | 1,199 | 6.7 | 6.3 | 5,775 |
| acute kidney injurySignal | 891 | 5.1 | 4.8 | 2,963 |
| off label useSignal | 2,355 | 2.4 | 2.3 | 1,925 |
| pyrexiaSignal | 834 | 2.1 | 2.0 | 497 |
| vomiting | 893 | 1.7 | 1.6 | 243 |
| drug ineffective | 1,888 | 1.3 | 1.2 | 105 |
| nausea | 1,065 | 1.2 | 1.1 | 30 |
| diarrhoea | 774 | 1.1 | 1.0 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.